907 related articles for article (PubMed ID: 12752460)
1. Anticonvulsant effect of flutamide on seizures induced by pentylenetetrazole: involvement of benzodiazepine receptors.
Ahmadiani A; Mandgary A; Sayyah M
Epilepsia; 2003 May; 44(5):629-35. PubMed ID: 12752460
[TBL] [Abstract][Full Text] [Related]
2. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
3. Anti-Seizure Activity of 1-Adamantane Carboxylic Acid in Common Experimental Seizure Models: Role of Benzodiazepine-GABAA Receptors.
Ghanbari E; Gavzan H; Khoshkroodian B; Sayyah M
Iran Biomed J; 2021 May; 25(3):213-9. PubMed ID: 33653022
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice.
Hansen SL; Sperling BB; Sánchez C
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):105-13. PubMed ID: 14687864
[TBL] [Abstract][Full Text] [Related]
5. Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy.
Borowicz KK; Luszczki JJ; Duda AM; Czuczwar SJ
Epilepsia; 2003 May; 44(5):640-6. PubMed ID: 12752462
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
Klitgaard H; Matagne A; Gobert J; Wülfert E
Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam.
Vlainić J; Pericić D
Neuropharmacology; 2009 Jun; 56(8):1124-30. PubMed ID: 19345234
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant effects of cyclosporin A on pentylenetetrazole-induced seizure and kindling: modulation by nitricoxidergic system.
Homayoun H; Khavandgar S; Dehpour AR
Brain Res; 2002 Jun; 939(1-2):1-10. PubMed ID: 12020845
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant profile of the imidazoquinazolines NNC 14-0185 and NNC 14-0189 in rats and mice.
Jackson HC; Hansen HC; Kristiansen M; Suzdak PD; Klitgaard H; Judge ME; Swedberg MD
Eur J Pharmacol; 1996 Jul; 308(1):21-30. PubMed ID: 8836628
[TBL] [Abstract][Full Text] [Related]
10. Acute and chronic effects of the synthetic neuroactive steroid, ganaxolone, against the convulsive and lethal effects of pentylenetetrazol in seizure-kindled mice: comparison with diazepam and valproate.
Gasior M; Ungard JT; Beekman M; Carter RB; Witkin JM
Neuropharmacology; 2000 Apr; 39(7):1184-96. PubMed ID: 10760361
[TBL] [Abstract][Full Text] [Related]
11. Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats.
De Sarro G; Di Paola ED; Gareri P; Gallelli L; Scotto G; De Sarro A
Eur J Pharmacol; 1999 Mar; 368(2-3):149-59. PubMed ID: 10193651
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the anticonvulsant properties of F-721.
Swinyard EA; Wolf HH; White HS; Skeen GA; Stark LG; Albertson T; Pong SF; Drust EG
Epilepsy Res; 1993 May; 15(1):35-45. PubMed ID: 8391982
[TBL] [Abstract][Full Text] [Related]
13. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models.
Löscher W; Hönack D; Fassbender CP; Nolting B
Epilepsy Res; 1991 Apr; 8(3):171-89. PubMed ID: 1907909
[TBL] [Abstract][Full Text] [Related]
14. Involvement of nitric oxide pathway in the acute anticonvulsant effect of melatonin in mice.
Yahyavi-Firouz-Abadi N; Tahsili-Fahadan P; Riazi K; Ghahremani MH; Dehpour AR
Epilepsy Res; 2006 Feb; 68(2):103-13. PubMed ID: 16406488
[TBL] [Abstract][Full Text] [Related]
15. Anti-epileptogenic effect of beta-carotene and vitamin A in pentylenetetrazole-kindling model of epilepsy in mice.
Sayyah M; Yousefi-Pour M; Narenjkar J
Epilepsy Res; 2005 Jan; 63(1):11-6. PubMed ID: 15716082
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital.
Löscher W; Nolting B; Hönack D
Eur J Pharmacol; 1988 Jul; 152(1-2):9-17. PubMed ID: 3061831
[TBL] [Abstract][Full Text] [Related]
17. Anticonvulsant profiles of the potent and orally active GABA uptake inhibitors SK&F 89976-A and SK&F 100330-A and four prototype antiepileptic drugs in mice and rats.
Swinyard EA; White HS; Wolf HH; Bondinell WE
Epilepsia; 1991; 32(4):569-77. PubMed ID: 1831122
[TBL] [Abstract][Full Text] [Related]
18. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.
Rostock A; Tober C; Rundfeldt C; Bartsch R; Engel J; Polymeropoulos EE; Kutscher B; Löscher W; Hönack D; White HS; Wolf HH
Epilepsy Res; 1996 Apr; 23(3):211-23. PubMed ID: 8739124
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant effects of iridoid glycosides fraction purified from Feretia apodanthera Del. (Rubiaceae) in experimental mice models of generalized tonic-clonic seizures.
Taiwe GS; Dabole B; Tchoya TB; Menanga JR; Dzeufiet PD; De Waard M
BMC Complement Altern Med; 2016 Aug; 16(1):285. PubMed ID: 27520389
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the neurosteroid alphaxalone with conventional antiepileptic drugs in different types of experimental seizures.
Borowicz KK; Zadrozniak M; Swiader M; Kowalska A; Kleinrok Z; Czuczwar SJ
Eur J Pharmacol; 2002 Aug; 449(1-2):85-90. PubMed ID: 12163110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
